ALEAF — Aleafia Health Cashflow Statement
0.000.00%
HealthcareHighly SpeculativeMicro Cap
- $0.00m
- $33.06m
- CA$42.85m
Annual cashflow statement for Aleafia Health, fiscal year end - March 31st, CAD millions except per share, conversion factor applied.
2018 December 31st | 2019 December 31st | 2020 December 31st | 2022 March 31st | 2023 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 15 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -18.5 | -39.6 | -247 | -170 | -34.6 |
Depreciation | |||||
Amortisation | |||||
Deferred Taxes | |||||
Non-Cash Items | 11.8 | 13.7 | 231 | 129 | 26.8 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -4.18 | -13.8 | 0.658 | -4.76 | -2.2 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Prepaid Expenses | |||||
Change in Other Assets | |||||
Change in Payable / Accrued Expenses | |||||
Change in Taxes Payable | |||||
Change in Other Liabilities | |||||
Net Change in Other Assets & Liabilities | |||||
Cash from Operating Activities | -10.3 | -30.9 | -7.63 | -36.2 | -3.48 |
Capital Expenditures | -12.1 | -16.1 | -17.8 | -4.66 | -1.65 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | 2.92 | 27.1 | 1.57 | 0 | 0.227 |
Acquisition of Business | |||||
Sale of Business | |||||
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -9.23 | 11 | -16.2 | -4.66 | -1.43 |
Financing Cash Flow Items | — | -2.95 | — | — | -2.04 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 44.9 | 34.7 | 13.1 | 11.9 | 3.96 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 25.3 | 14.8 | -10.7 | -29 | -0.942 |